Table 1.
Subject characteristics
| Characterization | N = 43 subjects | |
|---|---|---|
| Age in Years, Mean (SD) | 11.7 (4.2) | |
| Sex, N (%) | Male | 28 (65.1%) |
| Female | 15 (34.9%) | |
| Race, N (%) | White | 21 (48.8%) |
| Black | 6 (14.0%) | |
| Asian | 1 (2.3%) | |
| Otder | 10 (23.3%) | |
| Unknown | 5 (11.6%) | |
| Medication Step, Median(IQR) | 5.5 (4.5, 6) | |
| PHQ-4 score ≥ 1 | 25 (58.1%) | |
| PHQ-4 score >2 | 8 (18.6%) | |
| Time-Varying Covariates | N = 93 observations | |
| ACT Score, Mean (SD) | 18.6 (4.9) | |
| ACT Score (4–11 Years), Mean (SD) | 18.9 (4.5) | |
| ACT Score (12+ Years), Mean (SD) | 18.1 (5.4) | |
| FEV1% Predicted, Mean (SD) | 95.1 (18.4) | |
| FVC% Predicted, Mean (SD) | 102.0 (14.3) | |
| FEF25–75% Predicted, Mean (SD) | 86.4 (35.7) | |
| FEV1/FVC, Mean (SD) | 81.0 (9.4) | |
| PHQ-4 Score, Median (IQR) | 1.0 (0.0, 2.0) | |
| PHQ-4 Score > 0, N(%) | 49 (52.7%) | |
| PHQ-4 Score > 2, N(%) | 21 (22.6%) |